Current Opinion in Neurology

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	88
Update on management of cerebral venous thrombosis	57
The recent surge of functional movement disorders: social distress or greater awareness?	53
Management of neuropsychiatric symptoms in dementia	50
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	49
The role of the gut microbiome in Alzheimer's disease pathophysiology	44
Neurosyphilis in 2025: Erratum	43
Editorial introductions	43
Central nervous system adverse events of immune checkpoint inhibitors	38
From basic mechanisms to therapeutic perspectives in cluster headache	37
Historical development and contemporary use of neuromodulation in human spinal cord injury	34
Neurology education in the era of artificial intelligence	32
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	31
Gene therapies for CMT neuropathies: from the bench to the clinic	31
Microglia in multiple sclerosis – pathogenesis and imaging	30
Hereditary motor neuropathies	30
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	28
Editorial introductions	27
Updates in neuro-otology	26
Editorial: Epilepsy advances in 2023	24
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	24
Connecting tremors – a circuits perspective	23
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	22
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	22
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	22

Multiple sclerosis in China: the current state of diagnosis and management	22
Clinical impact of molecular profiling in rare brain tumors	21
Thymectomy in myasthenia gravis	21
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	21
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	21
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	21
Nerve ultrasound in the diagnosis of inflammatory neuropathies	21
Threat of resurgence or hope for global eradication of poliovirus?	21
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	20
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	20
Migraine in women: a review	20
The FSHD jigsaw: are we placing the tiles in the right position?	20
Levodopa infusion therapies for Parkinson disease	20
Idiopathic intracranial hypertension: expanding our understanding	19
Acute stroke care in low and middle-income countries	19
Red flags in multiple sclerosis	19
Gauging and controlling excitability in cortical disorders	19
MRI for the diagnosis of limb girdle muscular dystrophies	18
Electrical stimulation of the peripheral and central vestibular system	18
Obesity-related neuropathy: the new epidemic	18
fMRI-based spatio-temporal parcellations of the human brain	18
Diet and migraine: what is proven?	17
New developments in diagnostics and treatment of adult-onset focal dystonia	17
Update on dermatomyositis	17
Parkinson's disease – genetic cause	17
Novel approaches to treatment of leptomeningeal metastases	16
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	16
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	16
Targeting IDH1/IDH2 mutations in gliomas	16
Neurosyphilis in 2025	16
Editorial: The gap between academic advances and therapy development in motor neuron disease	16
Optic neuritis: current challenges in diagnosis and management	15
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	15
Progress in spinal muscular atrophy research	15
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	15
Neuroinflammation and immunometabolism in neurodegenerative diseases	15
Sex and gender differences in neurological infections	15
Recent advances in Alzheimer disease genetics	15
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	14
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond	14
The state of art on the use of patient reported outcomes in migraine	14
New insights in the immune treatment of Guillain–Barré syndrome	14
Monitoring multiple sclerosis: digital and fluid phase biomarkers	14
Fluid phase biomarkers in multiple sclerosis	14
Update on genetics of amyotrophic lateral sclerosis	14
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	14
Recent insights in striated muscle laminopathies	14
Current trend in air pollution exposure and stroke	14
Diagnosing viral encephalitis and emerging concepts	14
Visually induced dizziness	14

Editorial: Making the invisible visible: updates on vestibular neurology	13
Abnormal energy metabolism in ALS: a key player?	13
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	13
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	13
Advanced neuroimaging techniques in epilepsy	13
Imaging cortical lesions in multiple sclerosis	12
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy	12
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	12
Current gaps in acute reperfusion therapies	12
Update on modifiable risk factors for Alzheimer's disease and related dementias	12
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	12
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	11
Peripheral visual field loss and activities of daily living	11
Long COVID and especially headache syndromes	11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	11
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	11
Interrogating large multiple sclerosis registries and databases: what information can be gained?	11
Motion sickness: current concepts and management	11
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	11
Muscle ultrasound in myopathies	11
Multiple sclerosis: advances and challenges in diagnosis	11
Therapeutic thoroughfares for adults living with Pompe disease	11
Editorial: Seizure disorders: 2023 update	11
Pharmacotherapy of cerebellar and vestibular disorders	11
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	11
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	11
Perception and control of a virtual body in immersive virtual reality for rehabilitation	10
Nonneurologic causes of binocular diplopia for the neurologist	10
Editorial: Cerebrovascular disease	10
Ménière's disease: new guidelines, subtypes, imaging, and more	10
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	10
An update on psychogenic nonepileptic seizures	10
Progression in multiple sclerosis – a long-term problem	10
Progress in treatment of gliomas	10
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	10
Barriers to clinical genetic testing in movement disorders	9
Emerging concepts and therapies for amyotrophic lateral sclerosis	9
How to evaluate extent of resection in diffuse gliomas: from standards to new methods	9
The current landscape of epilepsy genetics: where are we, and where are we going?	9
Editorial: Advances in brain tumors management: new perspectives and challenges	9
Editorial introductions	9
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	9
New targets in spontaneous intracerebral hemorrhage	9
Editorial:Framing artificial intelligence to neuromuscular disorders	9
Neuro-infectious disorders – reasons to be cheerful but it is a long and winding road	9
Editorial introductions	9
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?	9
Atypical forms of Alzheimer's disease: patients not to forget	9
Editorial introductions	8
Vestibular and auditory manifestations of migraine	8
Lesion network mapping for symptom localization: recent developments and future directions	8
Shifting our attention earlier in the multiple sclerosis disease course	8
Editorial improving movement disorders healthcare across the globe	8
Headache in infections	8
Editorial: Advances in stroke management and upcoming challenges	8
Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined	8
Editorial introductions	8
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	7
Socioeconomic disparities in epilepsy care	7
Endogenous clues promoting remyelination in multiple sclerosis	7
Editorial: Current opinions in neurology editorial	7
Rescue therapies in epilepsy	7
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	7
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	7
Congenital myasthenic syndromes: increasingly complex	7
The genetics of amyotrophic lateral sclerosis	7
PET-based brain molecular connectivity in neurodegenerative disease	7
Imaging and neuromodulation in Parkinson's disease	7
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	6
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspective	6
Editorial introductions	6
Editorial introductions	6
Medical and neurologic management of brain tumor patients	6
Recent advances in epilepsy surgery	6
Novel pathophysiological insights in autoimmune myasthenia gravis	6
Recent insights into haematology and peripheral nerve disease	6
Editorial: Update on movement disorders	6
The role of caffeine in headache disorders	6
Emerging neuroinfectious diseases: public health implications	6

Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	6
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	6
Autoimmune neuromyotonia	6
Leprous neuropathy	6
Brain health in HIV: pathogenesis, classification, and treatment	6
Recent advances in the genetics of Parkinson's disease in underrepresented populations	6
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease	6
Novel trial designs in neuro-oncology	5
Advances in myopathy research: promising developments and challenges	5
Heterogeneity of frequencies of motor neuron disease across ethnicities and geographical areas: focus on Arabic countries in the Mediterranean area	5
Current understanding of skeletal muscle repeat expansion disorders	5
Persistent aura without infarction	5
Characterization, etiology, and management of neurocognitive impairment in patients with glioma: an evidentiary update	5
The evolving spectrum of complex inherited neuropathies	5
Autoimmune nodopathies, an emerging diagnostic category	5
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	5
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	5
Systemic vasculitis and headache	5
Ambulatory seizure detection	5
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	5
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	5
Current drug treatment of myasthenia gravis	5
Genetics of ALS – genes and modifier	5
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	5
An update on multiple system atrophy	5
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond	5
Defining the presymptomatic phase of frontotemporal dementia	5
Spasticity following brain and spinal cord injury: assessment and treatment	5
Neurotoxicity from chimeric antigen receptor T-cells: an update on diagnosis and treatment	5
Recent developments in multiple sclerosis neuropathology	5
Update on myelin imaging in neurological syndromes	5
Current concepts in acute vestibular syndrome and video-oculography	5
Vestibular syncope	5
The current clinical perception of myotonic dystrophy type 2	5
Editorial introductions	4
Late-onset myopathies	4
Traumatic brachial plexus injury: diagnosis and treatment	4
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	4
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	4
Re-defining progression in multiple sclerosis	4
Promoting exogenous repair in multiple sclerosis: myelin regeneration	4
Enzyme replacement therapies in adults with Pompe disease: from trials to real-world data	4
Recent advances, challenges and perspectives in cerebrovascular disease	4
Sudden unexpected death in epilepsy	4
Neuropathology and epilepsy surgery	4
Recent advances in our understanding of genetic rhabdomyolysis	4
Advances in functional and structural imaging of the brainstem: implications for disease	4
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials	4
Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review	4
Somatic mosaicism in focal epilepsies	4
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	4
Editorial: Degenerative and cognitive diseases	4
Intravenous thrombolysis for acute ischemic stroke: why not?	4
Reproducibility and replicability in neuroimaging data analysis	4
Myoclonus: an update	4
Immunology of multiple sclerosis: an update	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4